Skip to main content

Advertisement

Fig. 5 | BMC Cancer

Fig. 5

From: Demethylation of HIN-1 reverses paclitaxel-resistance of ovarian clear cell carcinoma through the AKT-mTOR signaling pathway

Fig. 5

a The average tumor size in xenograft mice after subcutaneous inoculation of 1 × 106 cells of ES2TR160 mock or ES2TR160 HIN-1 transfectants. b The average tumor sizes in xenograft mice after subcutaneous inoculation of 1 × 106 of ES2 or TOV21G cells with or without 5-aza-2-dC treatment. c The average tumor sizes in xenograft mice with subcutaneous inoculation of 1 × 106 of ES2TR160 cells with or without 5-aza-2-dC treatment

Back to article page